AngioLab, Inc.
Develops anti-angiogenic therapeutics and foods for angiogenesis-related diseases.
251280 | KO
Overview
Corporate Details
- ISIN(s):
- KR7251280004
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 테크노3로 65, 대전광역시
- Website:
- https://angiolab.co.kr/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
AngioLab, Inc. is a biotechnology company established in 1999 that specializes in the research and development of therapeutics based on angiogenesis inhibition. The company develops pharmaceuticals and health functional foods designed to treat a variety of angiogenesis-related diseases. Its core technology focuses on the discovery and application of anti-angiogenic and matrix metalloproteinase (MMP) inhibitors. AngioLab manages a pipeline of drug candidates, advancing them through clinical trials to create novel treatments for conditions driven by abnormal blood vessel formation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-10 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 63.7 KB | ||
| 2025-09-10 00:00 |
Regulatory News Service
기업설명회(IR)개최결과
|
Korean | 6.7 KB | ||
| 2025-07-17 00:00 |
Share Issue/Capital Change
기타주요경영사항(자율공시) (전환우선주의 보통주 전환)
|
Korean | 7.8 KB | ||
| 2025-04-23 00:00 |
Regulatory News Service
기업설명회(IR)개최결과
|
Korean | 6.7 KB | ||
| 2025-04-08 00:00 |
Share Issue/Capital Change
기타주요경영사항(자율공시) (전환우선주의 보통주 전환)
|
Korean | 7.8 KB | ||
| 2025-03-27 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 20.8 KB | ||
| 2025-03-20 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 4.9 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 9.6 KB | ||
| 2025-03-18 00:00 |
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
|
Korean | 342.5 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 261.5 KB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 12.8 KB | ||
| 2025-03-07 00:00 |
Remuneration Information
[기재정정]주식매수선택권부여에관한신고
|
Korean | 19.9 KB | ||
| 2025-03-07 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 18.7 KB | ||
| 2025-03-04 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 42.6 KB | ||
| 2025-02-25 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 5.1 KB |
Automate Your Workflow. Get a real-time feed of all AngioLab, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AngioLab, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AngioLab, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
